1029654-17-8 Usage
Uses
Used in Organic Synthesis:
2,4,6-Trimethylpyridine-3-boronic acid is used as a reagent in Suzuki-Miyaura cross-coupling reactions and other types of C-C bond formation. Its boronic acid functionality allows for the formation of stable complexes with diols and other nucleophiles, making it a versatile tool in the synthesis of various organic compounds.
Used in Pharmaceutical Industry:
2,4,6-Trimethylpyridine-3-boronic acid is used as a pharmaceutical intermediate for the synthesis of various drugs. Its unique structure and properties make it a valuable building block in the development of new pharmaceuticals with potential therapeutic applications.
Used in Agrochemical Industry:
2,4,6-Trimethylpyridine-3-boronic acid is used in the preparation of agrochemicals, such as pesticides and herbicides. Its ability to form stable complexes with various molecules makes it a useful component in the development of effective and targeted agrochemicals.
Used in Medicinal Chemistry:
2,4,6-Trimethylpyridine-3-boronic acid has been investigated for its potential medicinal properties, particularly as an anti-cancer agent. Its unique structure and ability to form stable complexes with biological molecules make it a promising candidate for the development of new cancer therapies. Further research is needed to fully understand its potential applications and mechanisms of action in the field of medicine.
Check Digit Verification of cas no
The CAS Registry Mumber 1029654-17-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,2,9,6,5 and 4 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1029654-17:
(9*1)+(8*0)+(7*2)+(6*9)+(5*6)+(4*5)+(3*4)+(2*1)+(1*7)=148
148 % 10 = 8
So 1029654-17-8 is a valid CAS Registry Number.
1029654-17-8Relevant academic research and scientific papers
PYRAZOLOQUINOLINE DERIVATIVES
-
Paragraph 0384, (2013/06/26)
A compound and/or pharmacologically acceptable salt thereof represented by the formula (I) has PDE9 inhibitory action, so that the intracerebral cGMP concentration is anticipated to be elevated. The PDE9 inhibitory action and the increase in cGMP lead to the improvement of learning and memory behaviors, and the compound (I) has applicability as a therapeutic agent for cognitive dysfunctions in Alzheimer's disease. wherein R1 is a hydrogen atom; R2 is an aromatic ring group, etc.; R3 is a hydrogen atom, etc; R4 is a hydrogen atom; R5 is an oxepanyl group, etc.; R6 is a hydrogen atom.
